For the past three years, nearly every breakthrough in obesity medicine has traced back to a single class of drugs: GLP-1 ...

Updates GLP drugs pricing and access highlight new subscription models, FDA approvals, and tighter regulatory oversight in 2024.

Millions of people have turned to GLP-1 drugs like Ozempic and Wegovy expecting dramatic results. Most get them. But for ...

In animal studies, an experimental drug targeting both GIP and glucagon led to equal or greater weight loss compared to ...

BENTONVILLE, Ark. (KNWA/KFTA) — GLP-1 blood testing is now being offered at select Sam’s Club locations in Texas through a partnership with Babson Diagnostics. The companies say the GLP-1 Test Panel ...

AUSTIN, TX / ACCESS Newswire / January 29, 2026 / BetterWay™ blood testing by Babson Diagnostics, a science-first healthcare technology company transforming diagnostic blood testing, announced today ...

NEW YORK – PrecisionLife and Ovation.io on Wednesday said they inked an agreement to launch a consumer-facing genetic test for identifying patients' likelihood of responding to GLP-1 receptor agonists ...

AUSTIN, Texas, April 9, 2026 /PRNewswire/ -- Choose Health, an at-home blood testing company specializing in liver and metabolic health, today announced the launch of the GLP-1 Health Monitoring ...

Phenomix's MyPhenome test continues to demonstrate predictive accuracy in identifying which patients are most likely to respond to GLP-1 therapies such as semaglutide. Studies presented at Obesity ...

Researchers say knowing that semaglutide improves liver health independently of weight loss could influence prescribing decisions.

Weight-loss responses to GLP-1 obesity drugs, and risks of side effects, may be linked to genetic variants, according to a ...